Abstract:Objectives. Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease characterized by chronic spinal inflammation, arthritis, gut inflammation, and enthesitis. We aimed to identify the key biomarkers related to immune infiltration and osteoclast differentiation in the pathological process of AS by bioinformatic methods. Methods. GSE25101 from the Gene Expression Omnibus was used to obtain AS-associated microarray datasets. We performed bioinformatics analysis using R software to validate different expression levels. The purpose of the GO and KEGG enrichment analyses of DEGs was to exclude key genes. Using weighted correlation network analysis (WGCNA), we examined all expression profile data and identified differentially expressed genes. The objective was to investigate the interaction between genetic and clinical features and to identify the essential relationships underlying coexpression modules. The CIBERSORT method was used to make a comparison of the immune infiltration in whole blood between the AS group and the control group. The WGCNA R program from Bioconductor was used to identify hub genes. RNA extraction reverse transcription and quantitative polymerase chain reaction were conducted in the peripheral blood collected from six AS patients and six health volunteers matched by age and sex. Results. 125 DEGs were identified, consisting of 36 upregulated and 89 downregulated genes that are involved in the cell cycle and replication processes. In the WGCNA, modules of MCODE with different algorithms were used to find 33 key genes that were related to each other in a strong way. Immune infiltration analysis found that naive CD4+ T cells and monocytes may be involved in the process of AS. PLCG2 and IFNAR1 genes were obtained by screening genes meeting the conditions of immune cell infiltration and osteoclast differentiation in AS patients among IGF2R, GRN, SH2D1A, LILRB3, IFNAR1, PLCG2, and TNFRSF1B. The results demonstrated that the levels of PLCG2 mRNA expression in AS were considerably higher than those in healthy individuals ( P=0.003 ). IFNAR1 mRNA expression levels were considerably lower in AS than in healthy individuals ( P<0.0001 ). Conclusions. Dysregulation of PLCG2 and IFNAR1 are key factors in disease occurrence and development of AS through regulating immune infiltration and osteoclast differentiation. Explaining the differences in immune infiltration and osteoclast differentiation between AS and normal samples will contribute to understanding the development of spondyloarthritis.

PDGFRB As a Potential Therapeutic Target of Ankylosing Spondylitis: Validation Following Bioinformatics Analysis.

Identification of the key genes and long non-coding RNAs in ankylosing spondylitis using RNA sequencing (vol 43, pg 1179, 2019)

Preosteoclast plays a pathogenic role in syndesmophyte formation of ankylosing spondylitis through the secreted PDGFB - GRB2/ERK/RUNX2 pathway

Screening for Key Genes and Transcription Factors in Ankylosing Spondylitis by RNA-Seq

Identification of potential biomarkers for ankylosing spondylitis based on bioinformatics analysis

Identification of immune related cells and crucial genes in the peripheral blood of ankylosing spondylitis by integrated bioinformatics analysis

PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood

Specific Gene Expression And Small-Molecule Drug Investigation In Ankylosing Spondylitis Under Interferon-Gamma Stimulation

Diagnostic biomarkers and potential treatment targets for Ankylosing Spondylitis

Identification of key genes in Ankylosing spondylitis.

Whole-blood Gene Expression Profiling in Ankylosing Spondylitis Identifies Novel Candidate Genes That May Contribute to the Inflammatory and Tissue-Destructive Disease Aspects.

Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening

Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers

RNA Sequencing for Gene Expression Profiles in Peripheral Blood Mononuclear Cells with Ankylosing Spondylitis RNA

RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients

A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis.

Role of ferroptosis-associated genes in ankylosing spondylitis and immune cell infiltration

Inorganic pyrophosphatase 1: a key player in immune and metabolic reprogramming in ankylosing spondylitis

Global Proteomic Analyses Reveals Abnormal Immune Regulation in Patients With New Onset Ankylosing Spondylitis

Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis

Upregulated of ANXA3, SORL1, and Neutrophils May Be Key Factors in the Progressionof Ankylosing Spondylitis